Acceleron Pharma, Inc.

Historical 13F Holders

Symbol
XLRN
CUSIP
00434H108
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q4 1 2.00 $358.00
2023 Q3 1 2.00 $358.00
2023 Q2 1 2.00 $358.00
2023 Q1 1 2.00 $358.00
2022 Q4 1 2.00 $358.00
2022 Q3 1 2.00 $0
2022 Q2 1 2.00 $0
2022 Q1 1 2.00 $0
2021 Q4 1 2.00 $0
2021 Q3 378 53.5 M $9.21 B
2021 Q2 290 54.4 M $6.82 B
2021 Q1 273 53.9 M $7.30 B
2020 Q4 272 54.2 M $6.93 B
2020 Q3 258 54.0 M $6.08 B
2020 Q2 269 48.5 M $4.62 B
2020 Q1 244 48.5 M $4.34 B
2019 Q4 204 49.2 M $2.61 B
2019 Q3 183 48.3 M $1.91 B
2019 Q2 187 48.5 M $1.99 B
2019 Q1 195 50.0 M $2.33 B
2018 Q4 175 45.0 M $1.96 B
2018 Q3 190 45.6 M $2.61 B
2018 Q2 195 41.5 M $2.01 B
2018 Q1 161 41.3 M $1.61 B
2017 Q4 146 40.1 M $1.70 B
2017 Q3 163 39.5 M $1.48 B
2017 Q2 137 34.6 M $1.05 B
2017 Q1 145 32.7 M $865 M
2016 Q4 154 32.6 M $832 M
2016 Q3 145 32.8 M $1.19 B
2016 Q2 141 30.1 M $1.02 B
2016 Q1 135 30.8 M $812 M
2015 Q4 137 25.0 M $1.22 B
2015 Q3 116 24.6 M $625 M
2015 Q2 120 24.7 M $782 M
2015 Q1 126 25.1 M $956 M
2014 Q4 123 24.8 M $968 M
2014 Q3 92 21.1 M $640 M
2014 Q2 98 21.1 M $715 M
2014 Q1 80 17.3 M $596 M